Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 7366-56-5 Chemical Structure| 7366-56-5
Chemical Structure| 7366-56-5

4-Thioureidobenzoic acid

CAS No.: 7366-56-5

4.5 *For Research Use Only !

Cat. No.: A179817 Purity: 97%

Change View

Size Price

US Stock

Global Stock

In Stock
250mg łÇ§¶ÊÊ Inquiry Inquiry
1g łË˶ÊÊ Inquiry Inquiry
5g łÿʶÊÊ Inquiry Inquiry
25g łÇî˶ÊÊ Inquiry Inquiry
100g łďËò¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 250mg

    łÇ§¶ÊÊ

  • 1g

    łË˶ÊÊ

  • 5g

    łÿʶÊÊ

  • 25g

    łÇî˶ÊÊ

  • 100g

    łďËò¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of [ 7366-56-5 ]

CAS No. :7366-56-5
Formula : C8H8N2O2S
M.W : 196.23
SMILES Code : O=C(O)C1=CC=C(NC(N)=S)C=C1
MDL No. :MFCD00041187
InChI Key :FOYDMXZTPAEILY-UHFFFAOYSA-N
Pubchem ID :736216

Safety of [ 7366-56-5 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301
Precautionary Statements:P501-P270-P264-P301+P310+P330-P405
Class:6.1
UN#:2811
Packing Group:

Calculated chemistry of [ 7366-56-5 ] Show Less

Physicochemical Properties

Num. heavy atoms 13
Num. arom. heavy atoms 6
Fraction Csp3 0.0
Num. rotatable bonds 3
Num. H-bond acceptors 2.0
Num. H-bond donors 3.0
Molar Refractivity 53.21
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

107.44 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.16
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.33
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

0.85
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

-0.32
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

1.06
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

0.82

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.04
Solubility 1.8 mg/ml ; 0.00916 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-3.19
Solubility 0.127 mg/ml ; 0.000649 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-1.62
Solubility 4.71 mg/ml ; 0.024 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

No
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.55 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

1.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.56

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.33
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 7366-56-5 ]

Aryls

Chemical Structure| 10541-83-0

A271033 [10541-83-0]

4-(Methylamino)benzoic acid

Similarity: 0.81

Chemical Structure| 1194804-60-8

A156517 [1194804-60-8]

3-(Methylamino)benzoic acid hydrochloride

Similarity: 0.78

Chemical Structure| 619-84-1

A404890 [619-84-1]

4-Dimethylaminobenzoic acid

Similarity: 0.77

Chemical Structure| 99-64-9

A224296 [99-64-9]

3-(Dimethylamino)benzoic acid

Similarity: 0.75

Chemical Structure| 66315-15-9

A267557 [66315-15-9]

3-Amino-4-(methylamino)benzoic acid

Similarity: 0.75

Amides

Chemical Structure| 731742-58-8

A131728 [731742-58-8]

2-Thioxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid

Similarity: 0.88

Chemical Structure| 23814-14-4

A279054 [23814-14-4]

2-Oxo-2,3-dihydro-1H-benzo[d]imidazole-5-carboxylic acid

Similarity: 0.72

Chemical Structure| 556-08-1

A259930 [556-08-1]

4-Acetamidobenzoic acid

Similarity: 0.72

Chemical Structure| 622-52-6

A621741 [622-52-6]

1-(p-Tolyl)thiourea

Similarity: 0.68

Chemical Structure| 37901-92-1

A169017 [37901-92-1]

4-Acetamido-3-methylbenzoic acid

Similarity: 0.68

Amines

Chemical Structure| 10541-83-0

A271033 [10541-83-0]

4-(Methylamino)benzoic acid

Similarity: 0.81

Chemical Structure| 1194804-60-8

A156517 [1194804-60-8]

3-(Methylamino)benzoic acid hydrochloride

Similarity: 0.78

Chemical Structure| 619-84-1

A404890 [619-84-1]

4-Dimethylaminobenzoic acid

Similarity: 0.77

Chemical Structure| 99-64-9

A224296 [99-64-9]

3-(Dimethylamino)benzoic acid

Similarity: 0.75

Chemical Structure| 66315-15-9

A267557 [66315-15-9]

3-Amino-4-(methylamino)benzoic acid

Similarity: 0.75

Carboxylic Acids

Chemical Structure| 731742-58-8

A131728 [731742-58-8]

2-Thioxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid

Similarity: 0.88

Chemical Structure| 10541-83-0

A271033 [10541-83-0]

4-(Methylamino)benzoic acid

Similarity: 0.81

Chemical Structure| 1194804-60-8

A156517 [1194804-60-8]

3-(Methylamino)benzoic acid hydrochloride

Similarity: 0.78

Chemical Structure| 619-84-1

A404890 [619-84-1]

4-Dimethylaminobenzoic acid

Similarity: 0.77

Chemical Structure| 66315-15-9

A267557 [66315-15-9]

3-Amino-4-(methylamino)benzoic acid

Similarity: 0.75

Thioureas

Chemical Structure| 622-52-6

A621741 [622-52-6]

1-(p-Tolyl)thiourea

Similarity: 0.68

Chemical Structure| 103-85-5

A271886 [103-85-5]

1-Phenylthiourea

Similarity: 0.60

Chemical Structure| 102-08-9

A350497 [102-08-9]

N,N'-Diphenylthiourea

Similarity: 0.59

Chemical Structure| 880-29-5

A693982 [880-29-5]

1-(4-Ethoxyphenyl)thiourea

Similarity: 0.57

Chemical Structure| 27079-29-4

A266135 [27079-29-4]

Methyl [(2-aminophenyl)carbamothioyl]carbamate

Similarity: 0.54